Coya Therapeutics, Inc. (COYA) Dividend History

Coya Therapeutics, Inc. (COYA) is a biopharmaceutical company focused on developing therapies for neurodegenerative and neuroinflammatory diseases. The company leverages cell-based and immunomodulatory approaches to address conditions such as amyotrophic lateral sclerosis (ALS) and other neurological disorders. Coya aims to advance innovative treatments that can modify disease progression and improve patient outcomes.

12645 Memorial Dr., Suite F1 #305, Houston, TX, 77024
Phone: 650.739.3939
Website: https://www.coyatherapeutics.com

Dividend History

Coya Therapeutics, Inc. currently does not pay dividends

Company News

Dr. Reddy's (RDY), COYA Ink Deal to Develop COYA 302 for ALS

Dr. Reddy's (RDY) enters into a licensing agreement with Coya Therapeutics to develop and commercialize the latter's ALS investigational combination therapy, COYA 302.

Zacks Investment Research

Featured Companies: AGEN PBYI
Rare Stock Picks In August 2023 - From 34 Discerning Analysts

We've compiled a list of August investment picks that you may have missed. Some Seeking Alpha analysts are more discerning by nature. See their Buy recommendations here.

Seeking Alpha

Featured Companies: ARLO ATUS AZO BDTX CFG CHWY CRM DCTH EXPI FOUR FSI GSM HOOD HSY LEVI LOW MP MSGS NDLS NVDA PH PYPL SMIN TACT TDOC TPYP VTR VTS X
Analyst Expectations for Coya Therapeutics's Future

Within the last quarter, Coya Therapeutics (NASDAQ:COYA) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 8 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 3 0 0 0 0 3M Ago 4 0 0 0 0 According to 8 analyst offering 12-month price targets in the last 3 months, Coya Therapeutics has an average price target of $19.75 with a high of $28.00 and a low of $9.00. Below is a summary of how these ...Full story available on Benzinga.com

Benzinga

Page data last updated 07/23/2025 15:02:50 UTC